ECCN18. 7th European Conference on Clinical Neuroimaging
Brussels, Belgium. 26th – 27th March.
Spring meeting of Sociedad Madrileña de Medicina Nuclear
March 15th, Madrid.
University Hospital Quirónsalud Madrid, assembly hall.
Successfully installed and tested at Mayo Clinic, Ruber International and University of California, San Francisco (UCSF), Mammi software 2.2 features...Read more
Oncovision has been present in several events and congresses promoting its product portfolio directly or through its distributors with great success.Read more
Palma de Mallorca, from 24th to 26th of May. Visit us at booth 9Read more
Ella Jones, PhD, an imaging specialist at the University of California, San Francisco commented on her experience with MAMMI dedicated breast PET (dbPET).
Inter- and intra-tumoral heterogeneity in breast cancer poses challenges to the paradigm of precision medicineRead more
Jose Ferrer Rebolleda, Medical Director of ERESA, describes his experience with MAMMI dedicated breast PET (MammiPET)
When it comes to talking about mammo-dedicated technology, MammiPET is an important step forward in the early detection of breast cancer.Read more
Due to the World Breast Cancer month in October, our Mammi reference centers wanted to share with us a very special picture.Read more
S. Leong is leading a melanoma clinical study with Sentinella. 100 patients are included where the primary goal is to locate and remove sentinel lymph nodes that can be missed by the current ...Read more
Oncovision will develop CareMiBrain, the first commercial PET scanner specifically for the brain and intended to help in the early diagnosis of Alzheimer´s disease. This constitutes...Read more
Value-creating divestment supports OncoVision focus on the clinical business while Bruker strengthens its leadership in preclinical imagingRead more
The study is directed by Dr. Leong of California Pacific Medical Center in San Francisco, and evaluates the intraoperatory use of Sentinella in the Sentinel Node ...Read more